March 18, 2020 – COVID-19
Clarifications regarding DF/HCC consent requirements for human subject oncology research in response to shared Partner's communications
The information on this page applies to all research conducted under the Dana-Farber/Harvard Cancer Center.
For additional information please see:
Please also consult officials at your home institution for specific information about restrictions, guidance, and changes at your institution.
March 18, 2020 – COVID-19
Clarifications regarding DF/HCC consent requirements for human subject oncology research in response to shared Partner's communications
March 14, 2020 – COVID-19
To all staff participating in human subject research at DF/HCC: Below is some additional information to clarify what changes require prospective review and approval by the DFCI IRB in light of the steps we…